91 research outputs found

    Di-μ-sulfato-κ4 O:O′-bis­[diaqua­(1H-imidazo[4,5-f][1,10]phenanthroline-κ2 N 7,N 9)cobalt(II)] dihydrate

    Get PDF
    In the centrosymmetric dinuclear title compound, [Co2(SO4)2(C13H8N4)2(H2O)4]·2H2O, the CoII atom is coord­in­ated by two N atoms from two 1H-imidazo[4,5-f][1,10]phenanthroline ligands, two O atoms from two sulfate anions and two O atoms from water mol­ecules in a distorted octa­hedral geometry. The Co⋯Co separation is 5.1167 (7) Å. The coordinated and uncoordinated water mol­ecules engage in N—H⋯O and O—H⋯O hydrogen-bonding inter­actions

    Linearized Relative Positional Encoding

    Full text link
    Relative positional encoding is widely used in vanilla and linear transformers to represent positional information. However, existing encoding methods of a vanilla transformer are not always directly applicable to a linear transformer, because the latter requires a decomposition of the query and key representations into separate kernel functions. Nevertheless, principles for designing encoding methods suitable for linear transformers remain understudied. In this work, we put together a variety of existing linear relative positional encoding approaches under a canonical form and further propose a family of linear relative positional encoding algorithms via unitary transformation. Our formulation leads to a principled framework that can be used to develop new relative positional encoding methods that preserve linear space-time complexity. Equipped with different models, the proposed linearized relative positional encoding (LRPE) family derives effective encoding for various applications. Experiments show that compared with existing methods, LRPE achieves state-of-the-art performance in language modeling, text classification, and image classification. Meanwhile, it emphasizes a general paradigm for designing broadly more relative positional encoding methods that are applicable to linear transformers. The code is available at https://github.com/OpenNLPLab/Lrpe.Comment: Reviewed by TMLR, decision pending. Yiran Zhong is the corresponding author. Code is available at https://github.com/OpenNLPLab/Lrp

    Fine-grained Audible Video Description

    Full text link
    We explore a new task for audio-visual-language modeling called fine-grained audible video description (FAVD). It aims to provide detailed textual descriptions for the given audible videos, including the appearance and spatial locations of each object, the actions of moving objects, and the sounds in videos. Existing visual-language modeling tasks often concentrate on visual cues in videos while undervaluing the language and audio modalities. On the other hand, FAVD requires not only audio-visual-language modeling skills but also paragraph-level language generation abilities. We construct the first fine-grained audible video description benchmark (FAVDBench) to facilitate this research. For each video clip, we first provide a one-sentence summary of the video, ie, the caption, followed by 4-6 sentences describing the visual details and 1-2 audio-related descriptions at the end. The descriptions are provided in both English and Chinese. We create two new metrics for this task: an EntityScore to gauge the completeness of entities in the visual descriptions, and an AudioScore to assess the audio descriptions. As a preliminary approach to this task, we propose an audio-visual-language transformer that extends existing video captioning model with an additional audio branch. We combine the masked language modeling and auto-regressive language modeling losses to optimize our model so that it can produce paragraph-level descriptions. We illustrate the efficiency of our model in audio-visual-language modeling by evaluating it against the proposed benchmark using both conventional captioning metrics and our proposed metrics. We further put our benchmark to the test in video generation models, demonstrating that employing fine-grained video descriptions can create more intricate videos than using captions.Comment: accpeted to CVPR 2023, Xuyang Shen, Dong Li and Jinxing Zhou contribute equally, code link: github.com/OpenNLPLab/FAVDBench, dataset link: www.avlbench.opennlplab.c

    A preclinical animal study to evaluate the operability and safety of domestic one-way endobronchial valves

    Get PDF
    PurposeTo evaluate the operability and safety of bronchoscopic domestic one-way endobronchial valves (EBV) on animals.MethodsNine pigs were randomly assigned (2:1) to receive domestic one-way EBV (the experimental group, n = 6) and Zephyr® EBV (the control group, n = 3). Routine blood tests, arterial blood gases, and CT scans of the lungs were performed 1 day pre-procedure in addition to 1 week and 1 month post-procedure to assess changes in blood markers and lung volumes. At 1 month post-procedure, the animals were sacrificed, followed by removal of all valves via bronchoscopy. Pathological examinations of critical organs were subsequently performed.ResultsA total of 15 valves were placed in the experimental group and 6 valves were placed in the control group, without serious complications. Routine blood tests and arterial blood gas examinations at 1 day pre-procedure, 1 week post-procedure, and 1 month post-procedure did not differ significantly in both groups. No EBV displacement was noted under bronchoscopy, and the valve was smoothly removable by bronchoscope at 1 month post-procedure. At 1 week post-procedure, varying degrees of target lung lobe volume reduction were observed on lung CT in both groups. Lung volume reduction was achieved at 1 month post-procedure in both groups, without significant statistical difference. Although 3 cases in the experimental group and 1 case in the control group developed varying degrees of pneumonia, the inflammatory response did not increase over time during the experimental period. Pathological examination revealed no significant abnormal changes in the critical organs for both groups.ConclusionOur results demonstrate that domestic EBV is safe and reliable for endobronchial application in general-grade laboratory white pigs. The safety of domestic EBV is similar to that of Zephyr® EBV, with good ease of use and operability. This kind of domestic EBV can meet the safety evaluation requirements for animal testing

    Predictive value of the resistance of the probe to pass through the lesion in the diagnosis of peripheral pulmonary lesions using radial probe endobronchial ultrasound with a guide sheath

    Get PDF
    BackgroundTransbronchial lung biopsy guided by radial probe endobronchial ultrasonography with a guide sheath (EBUS-GS-TBLB) is becoming a significant approach for diagnosing peripheral pulmonary lesions (PPLs). We aimed to explore the clinical value of the resistance of the probe to pass through the lesion in the diagnosis of PPLs when performing EBUS-GS-TBLB, and to determine the optimum number of EBUS-GS-TBLB.MethodsWe performed a prospective, single-center study of 126 consecutive patients who underwent EBUS-GS-TBLB for solid and positive-bronchus-sign PPLs where the probe was located within the lesion from September 2019 to May 2022. The classification of probe resistance for each lesion was carried out by two bronchoscopists independently, and the final result depended on the bronchoscopist responsible for the procedures. The primary endpoint was the diagnostic yield according with the resistance pattern. The secondary endpoints were the optimum number of EBUS-GS-TBLB and factors affecting diagnostic yield. Procedural complications were also recorded.ResultsThe total diagnostic yield of EBUS-GS-TBLB was 77.8%, including 83.8% malignant and 67.4% benign diseases (P=0.033). Probe resistance type II displayed the highest diagnostic yield (87.5%), followed by type III (81.0%) and type I (61.1%). A significant difference between the diagnostic yield of malignant and benign diseases was detected in type II (P = 0.008), whereas others did not. Although most of the malignant PPLs with a definitive diagnosis using EBUS-GS-TBLB in type II or type III could be diagnosed in the first biopsy, the fourth biopsy contributed the most sufficient biopsy samples. In contrast, considerably limited tissue specimens could be obtained for each biopsy in type I. The inter-observer agreement of the two blinded bronchoscopists for the classification of probe resistance was excellent (κ = 0.84).ConclusionThe probe resistance is a useful predictive factor for successful EBUS-GS-TBLB diagnosis of solid and positive-bronchus-sign PPLs where the probe was located within the lesion. Four serial biopsies are appropriate for both probe resistance type II and type III, and additional diagnostic procedures are needed for type I

    Chemotherapy-induced nausea and vomiting among cancer patients in Shanghai: a cross-sectional study

    Get PDF
    Background and purpose: Chemotherapy-induced nausea and vomiting (CINV) can cause severe damage to body functions and even lead to death. The prevention of CINV is critically important in patients receiving emetogenic chemotherapy regimen. This study aimed to investigate the prevalence and treatment of CINV in Grade-A tertiary hospitals in Shanghai and explore risk factors of CINV to improve its management. Methods: The clinical data of 376 cancer patients in Grade-A tertiary hospitals in Shanghai from October 2022 to December 2022 were collected retrospectively. The questionnaire was used to conduct a cross-sectional study. The univariate and multivariable logistic regression models were used to evaluate the influencing factors of CINV. Results: The management and coincidence of the guideline in 2022 significantly improved compared to five years ago. For patients receiving high-emetic-risk chemotherapy regimen, the coincidence of the guideline increased from 21.6% to 67.0%. For patients receiving moderate-emetic-risk chemotherapy regimen, the neurokinin-1 (NK-1) receptor antagonist was not significantly associated with CINV. Multivariable analysis showed that the chemotherapy regimen was the only risk factor for CINV during the whole period (P<0.05). Conclusion: The chemotherapy regimen is the main risk factor for CINV. To control CINV better, clinical practitioners should focus on the intrinsic risk of chemotherapy regimens preferentially, estimate the risk and adhere better to guidelines
    corecore